Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma
Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The current study is being conducted to evaluate the possibility that a different schedule of
bortezomib, doxorubicin HCl liposome, and dexamethasone might decrease the incidence of
peripheral neuropathy yet maintain similar efficacy and allow maintenance of bortezomib
dosing for a longer period.